SCHEMBL22708646

SCHEMBL22708646

c1ccc2c(c1)[nH]c1ccc3c(oc4cc(-c5cccc6c5oc5ccccc56)c5ccccc5c43)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.45
▸ JAK2 O60674 1/20 0.41
▸ ZAP70 P43403 1/20 0.41
▸ SYK P43405 1/20 0.41
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ GABRA4 P48169 1/20 0.39
▸ GABRE P78334 1/20 0.39
▸ GABRA6 Q16445 1/20 0.39
▸ GABRG1 Q8N1C3 1/20 0.39
▸ GABRG3 Q99928 1/20 0.39
▸ GABRQ Q9UN88 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708502 0.90 ALOX5 (0.45) ALOX5JAK2ZAP70SYKGABRP
SCHEMBL31846 0.85 GABRA1 (0.51) JAK2ZAP70SYKGABRPGABRD
SCHEMBL29819648 0.85 GABRA1 (0.51) JAK2ZAP70SYKGABRPGABRD
SCHEMBL29655467 0.85 GABRA1 (0.51) JAK2ZAP70SYKGABRPGABRD
SCHEMBL23676937 0.84 ALOX5 (0.50) ALOX5JAK2ZAP70SYKGABRP
SCHEMBL22708473 0.83 GABRP (0.38) ALOX5JAK2ZAP70SYKGABRP
SCHEMBL22708418 0.82 HPGD (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL18926345 0.81 GABRA1 (0.50) JAK2ZAP70SYKGABRPGABRD
SCHEMBL18621478 0.79 GABRA1 (0.61) JAK2ZAP70SYKGABRPGABRD
SCHEMBL19968109 0.79 JAK2 (0.48) JAK2ZAP70SYKGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 ALOX5 669/4885JAK2 2326/4885ZAP70 4702/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 ALOX5 669/4885JAK2 2326/4885ZAP70 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback